This small molecule offers potential advantages over the PTD-DBM peptide: better stability, easier manufacturing, potentially superior skin penetration, and a path through standard pharmaceutical clinical trials
FDA considers adding a dozen peptides to its bulk drug compounding list
they are both controlled substances in that they can only be prescribed and administered by a physician or credentialed healthcare provider
DSIPs limited data suggest potential sleep-promoting effects without significant next-day cognitive impairment, though comparative trials are lacking
Research indicates its ability to: Stimulate Collagen and Elastin Production: These essential proteins are crucial for skin structure, firmness, and elasticity
One study looked at oral glutathione supplements at dosages of either 250 mg per day or 1000 mg per day over six months